CI vs ELV
The Cigna Group and Elevance Health, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CI | ELV |
|---|---|---|
| Revenue | $274.9B | $199.1B |
| Net income | $6.0B | $5.7B |
| Gross margin | 21.8% | 89.4% |
| Net margin | 2.2% | 2.8% |
| Return on equity | 14.4% | 13.3% |
| Diluted EPS | $22.18 | $25.21 |
| Dividend / share | $6.04 | $5.92 |
| Payout ratio | 27.0% | 27.0% |
| Free cash flow | $8.4B | $3.2B |
| Equity | $41.7B | $43.9B |
| Net debt / equity | 0.57× | 0.51× |
| Current ratio | 0.85× | 1.54× |
| Revenue CAGR 5y | 11.4% | 10.3% |
| Profit CAGR 5y | −6.8% | 4.4% |
CI bills 1.4× the revenue of ELV, and ELV keeps more of each dollar of revenue as profit (2.8% against 2.2%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | CI | ELV |
|---|---|---|
| FY2025 | $274.9B | $199.1B |
| FY2024 | $247.1B | $177.0B |
| FY2023 | $195.3B | $171.3B |
| FY2022 | $180.5B | $156.6B |
| FY2021 | $174.1B | $138.6B |
| FY2020 | $160.4B | $121.9B |
| FY2019 | $153.6B | $104.2B |
| FY2018 | $48.6B | $92.1B |
| FY2017 | $41.8B | $90.0B |
| FY2016 | $39.8B | $84.9B |
Net income by year
Bottom line
| Fiscal year | CI | ELV |
|---|---|---|
| FY2025 | $6.0B | $5.7B |
| FY2024 | $3.4B | $6.0B |
| FY2023 | $5.2B | $6.0B |
| FY2022 | $6.8B | $5.9B |
| FY2021 | $5.4B | $6.2B |
| FY2020 | $8.5B | $4.6B |
| FY2019 | $5.1B | $4.8B |
| FY2018 | $2.6B | $3.8B |
| FY2017 | $2.2B | $3.8B |
| FY2016 | $1.8B | $2.5B |
Advertisement
AdSense · Rectangle 336×280